Navigation Links
Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C
Date:7/22/2014

er 2012 in order to license, develop and commercialize various novel therapeutic and diagnostic technologies for the Blanchette Rockefeller Neurosciences Institute (BRNI). Neurotrope's pipeline currently includes the drug candidate, bryostatin, for the treatment of Alzheimer's disease; a minimally invasive, diagnostic biomarker analysis system which will assess the presence of Alzheimer's in patients, and; potent treatments for a number of orphan diseases, including Fragile X Syndrome. The Company's preclinical and clinical efforts are focused on the development of conventional small molecules that are extraordinarily potent in the activation of the enzyme PKCepsilon, which has been shown to play a central role in the regrowth or repair of nervous tissues, cells or cell products. A Phase 2a study with bryostatin in the treatment of Alzheimer's disease, being developed in collaboration with BRNI, is currently underway.

Please visit www.neurotropebioscience.com for further information.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the development of commercially viable pharmaceuticals, (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items, (iii) the Company's future financial performance and (iv) the assumptions underlying or relating to any statement described in points (i), (ii) or (iii) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Compan
'/>"/>

SOURCE Neurotrope, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Neurotrope, Inc., Announces Reverse Merger and Completion of $21.9 Million Private Offering
2. Neurotrope, Inc., Appoints Paul E. Freiman to the Companys Board of Directors
3. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
4. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
5. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
6. 3 Pediatric Centers that Offer SynCardia Total Artificial Heart Named in Top 10 for "Best Childrens Hospitals"
7. Abaxis Enters Into Definitive Agreement To Deliver 300 Piccolo Xpress Instruments For A Four-Year Drug Clinical Trial
8. The Galien Foundation Announces Roster of Luminary Presenters for Third Galien Forum; Program Highlights Include CEO Panel, Panel on Alzheimers Disease Innovation, Nobel Laureate Elie Wiesel
9. ApolloMed ACO Selected To Participate In A Transformative New Initiative Sponsored by the Centers for Medicare and Medicaid Services
10. Spine Pain Management Opens Two Additional Affiliate Diagnostic Centers in Florida
11. Caspase Inhibitor Enters Clinical Trial In Islet Transplantation As Treatment For Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... SHENZHEN, China , May 22, 2015  China ... the "Company"), a leading retail drugstore chain in ... directly operated stores, today announced the resignation of Mr. ... Officer for personal reasons, effective immediately. Ms. Rebecca ... Officer by the Company,s board of directors, effective immediately. ...
(Date:5/21/2015)... Research and Markets ... of the "Arthroscopy Devices Markets Worldwide" ... http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose of this report ... market for Arthroscopy Devices. The report discusses ... market for these products. , ,Product - ...
(Date:5/21/2015)... , 21. Mai 2015 /PRNewswire/ ... DPRX ), ein Unternehmen für Arzneimittel ... die Entwicklung und Vermarktung von Locilex® ... kündigte heute eine wissenschaftliche Posterpräsentation an, ... des Unternehmens vorstellt, OneStep-1 und OneStep-2, ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... RESTON, Virginia, August 25, 2011 ... Wi-Fi-based Real Time Location Systems (RTLS), ... been integrated into a healthcare telecommunications system developed ... will provide location tracking capabilities to HEALTHCAREwireless™, which ...
... Aug. 25, 2011 QRxPharma Limited (ASX: QRX and ... Application (NDA) clinical data package to the United States ... immediate-release Dual Opioid® pain therapy comprised of a patented ... NDA Chemistry, Manufacturing and Controls (CMC) module was submitted ...
Cached Medicine Technology:Ekahau Joins Forces with LPS Services to Deliver Location Tracking for HEALTHCAREwireless™ Solution 2Ekahau Joins Forces with LPS Services to Deliver Location Tracking for HEALTHCAREwireless™ Solution 3QRxPharma Completes NDA Submission for MoxDuo® IR 2QRxPharma Completes NDA Submission for MoxDuo® IR 3
(Date:5/24/2015)... The Rolling Stones Zip Code summer stadium ... Petco Park. This iconic group is ready for their ... had a warmup show in Los Angeles at the Henry ... this beloved band not only played their Sticky Fingers album ... "Jumping Jack Flash," "Moonlight Mile" and "All Down the ...
(Date:5/24/2015)... May 24, 2015 Scientists with Cardno ... on air quality compliance issues that may have raised ... Surviving Mesothelioma has just posted an article on the ... , The group found airborne asbestos levels well above ... between 1984 and 2011. , “Asbestos compliance sampling data ...
(Date:5/24/2015)... 24, 2015 Indiana Fiber Network, LLC ... Midwest Telecom of America, Inc. (MTA) has selected IFN ... Cory Childs, IFN Enterprise Sales Manager, fiber route diversity ... “IFN’s fiber transport provides MTA with the diverse fiber ... Tier 1 Internet and voice carriers located at Henry ...
(Date:5/23/2015)... City, FL (PRWEB) May 23, 2015 On ... to build a new playground for Branches Florida City exactly ... the former play space in 2010. , A large fire ... new playground on May 23, 2010 in the middle of ... watched. The fire was later declared arson even though it ...
(Date:5/23/2015)... York, NY (PRWEB) May 23, 2015 ... announced that, “the company has been the target ... as a part of the company’s ongoing Information Technology ... on health insurers.” , The most notable attack ... year when Anthem Inc., the nation’s second largest health ...
Breaking Medicine News(10 mins):Health News:The Rolling Stones Tickets in San Diego, Orlando, Minneapolis, Dallas, Pittsburgh, Indianapolis, Atlanta, Detroit, Milwaukee, Kansas City, Columbus, Nashville & Raleigh 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4
... leading spinal surgeons who was keenly interested in Buddhism and traveled ... died at the age// of 93. ,Born in 1913, ... to Winchester College at the age of 13 and received a ... and biochemistry. ,In 1934 Roaf's parents moved from London ...
... for the treatment of their thalassaemic daughter are drying up. ... to spread awareness about the disease.// ,Meet Samir ... the knot, they didn't know how thalassaemia could affect their ... a premarital blood detection test and initiated an awareness campaign ...
... in animal evolution has puzzled scientists for centuries. Vertebrates, ... their CNSs are different and were thought to have ... Researchers from the European Molecular Biology Laboratory [EMBL] in ... probably much older than expected. The study, which is ...
... to pull up its socks on health issues, lest it ... of chronic diseases’. If the present trend continues//, 66% of ... ,A study conducted by Assocham and Price Waterhouse ... shown the vulnerability of the Indian population to cardiovascular disease. ...
... motivating seniors and others with Medicare to make the most ... Department of Health and Human Services (HHS) and the Centers ... A Healthier US Starts Here. , ... the Medicare Prevention tour bus will visit each of the ...
... Administration (FDA) is alerting health care professionals and consumers ... drug safety information. The broadcasts, commonly known as podcasts, ... players. ,The service is part of the ... concerning the safety of marketed medications when unexpected ...
Cached Medicine News:Health News:Thalassaemic Child's Parents Campaign for Awareness 2Health News:The Origin of the Brain Lies in a Worm 2Health News:Seniors Encouraged To Make Use Of Medicare’s Freebie 2Health News:FDA Announces Audio Broadcasts on Emerging Drug Safety Information 2